Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 3′-(Substituted Phenyl)epibatidine analogues. Nicotinic partial agonists⊥

Journal of Natural Products

Volumn 73, Issue 3, 2010, Pages 306-312

  Ivy Carroll, F ^a   Ma, Wei ^a   Deng, Liu ^a   Navarro, Hernán A ^a   Imad Damaj, M ^b   Martin, Billy R ^b  

^a Research Triangle Institute   (Australia)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3' (3 AMINOPHENYL)EPIBATIDINE; 3' (3 CHLOROPHENYL)EPIBATIDINE; 3' (3 DIMETHYLAMINOPHENYL)EPIBATIDINE; 3' (3 FLUOROPHENYL)EPIBATIDINE; EPIBATIDINE; EPIBATIDINE DERIVATIVE; NICOTINE; NICOTINIC RECEPTOR; UNCLASSIFIED DRUG; VARENICLINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; HOT PLATE TEST; HYPOTHERMIA; MALE; NONHUMAN; RAT; REACTION ANALYSIS; RECEPTOR AFFINITY; TAIL FLICK TEST;

ANALGESICS; ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; MALE; MICE; MOLECULAR STRUCTURE; NICOTINIC AGONISTS; PYRIDINES; RATS; RECEPTORS, NICOTINIC;

EID: 77950401811     PISSN: 01633864     EISSN: 15206025     Source Type: Journal    
DOI: 10.1021/np9006124     Document Type: Article

References (21)

1. Ezzati, M.; Lopez, A. D. Lancet 2003, 362, 847-852.
2. Henningfield, J. E.; Fant, R. V.; Buchhalter, A. R.; Stitzer, M. L. CA Cancer J. Clin. 2005, 55, 281-299.
3. Keating, G. M.; Siddiqui, M. A. A. CNS Drugs 2006, 20, 945-960.
4. Niaura, R.; Jones, C.; Kirkpatrick, P. Nat. Rev. Drug Discovery 2006. 5, 537-538.
5. Spande, T. F.; Garraffo, H. M.; Edwards, M. W.; Yen, H. J. C.; Pannell, L.; Daly, J. W. J. Am. Chem. Soc.1992, 114, 3475-3478.
6. Molina, P. E.; Ding, Y. S.; Carroll, F. I.; Liang, F.; Volkow, N. D.; Pappas, N.; Kuhar, M.; Abumrad, N.; Gatley, S. J.; Fowler, J. S. Nucl. Med. Biol. 1997, 24, 743-747.
7. Rao, T. S.; Correa, L. D.; Reid, R. T.; Lloyd, G. K. Neuropharmacology 1996, 35, 393-405.
8. Bonhaus, D. W.; Bley, K. R.; Broka, C. A.; Fontana, D. J.; Leung, E.; Lewis, R.; Shieh, A.; Wong, E. H. J. Pharmacol. Exp. Ther. 1995, 272, 1199-1203.
9. Sullivan, J. P.; Decker, M. W.; Brioni, J. D.; Donnelly-Roberts, D.; Anderson, D. J.; Bannon, A. W.; Kang, C. H.; Adams, P.; Piattoni-Kaplan, M.; Buckley, M. J.; Gopalakrishnan, M.; Williams, M.; Arneric, S. P. J. Pharmacol. Exp. Ther. 1994, 271, 624-631.
10. Lloyd, G. K.; Williams, M. J. Pharmacol. Exp. Ther. 2000, 292, 461-467.
11. Carroll, F. I. Bioorg. Med. Chem. Lett. 2004, 14, 1889-1896.
12. Carroll, F. I.; Brieaddy, L. E.; Navarro, H. A.; Damaj, M. I.; Martin, B. R. J. Med. Chem. 2005, 48, 7491-7495.
13. Carroll, F. I.; Lee, J. R.; Navarro, H. A.; Brieaddy, L. E.; Abraham, P.; Damaj, M. I.; Martin, B. R. J. Med. Chem. 2001, 44, 4039-4041.
14. Carroll, F. I.; Lee, J. R.; Navarro, H. A.; Ma, W.; Brieaddy, L. E.; Abraham, P.; Damaj, M. I.; Martin, B. R. J. Med. Chem. 2002, 45, 4755-4761.
15. Carroll, F. I.; Liang, F.; Navarro, H. A.; Brieaddy, L. E.; Abraham, P.; Damaj, M. I.; Martin, B. R. J. Med. Chem. 2001, 44, 2229-2237.
16. Carroll, F. I.; Ma, W.; Yokota, Y.; Lee, J. R.; Brieaddy, L. E.; Navarro, H. A.; Damaj, M. I.; Martin, B. R. J. Med. Chem. 2005, 48, 1221-1228.
17. Carroll, F. I.; Ware, R.; Brieaddy, L. E.; Navarro, H. A.; Damaj, M. I.; Martin, B. R. J. Med. Chem. 2004, 47, 4588-4594.
18. Abdrakhmanova, G.; Damaj, M. I.; Carroll, F. I.; Martin, B. R. Mol. Pharmacol. 2006, 69, 1945-1952.
19. Carroll, F. I.; Yokota, Y.; Ma, W.; Lee, J. R.; Brieaddy, L. E.; Burgess, J. P.; Navarro, H. A.; Damaj, M. I.; Martin, B. R. Bioorg. Med. Chem. 2008, 16, 746-754.
20. Navarro, H. A.; Xu, H.; Zhong, D.; Abraham, P.; Carroll, F. I. Synapse 2002, 44, 117-123.
21. D'Amour, F. E.; Smith, D. L. J. Pharmacol. Exp. Ther. 1941, 72, 74-79.